Biomet’s net sales were also up 4.5 percent this past quarter, totaling $825.7 million. Spine sales increased 2.3 percent from $102.6 million to $104.9 million. The biggest growth was seen in knees, which increased 6.6 percent to $264 million.
The company’s 2012 acquisition of DePuy Orthopaedic’s trauma products has helped increase growth over the last year.
More Articles on Devices:
Where the Spine Device Field is Headed: Q&A With Invibio’s Michael Veldman
Stryker, NeuroLogica Enter Exclusive Partnership Agreement to Better Facilitate Image-Guided Surgery
Device Companies — 11 Key Notes — Medtronic, Stryker, Zimmer & More
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
